Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-079097
Filing Date
2025-04-11
Accepted
2025-04-11 16:05:32
Documents
17
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d900407ddef14a.htm   iXBRL DEF 14A 669285
3 GRAPHIC g900407g0404235412721.jpg GRAPHIC 6390
4 GRAPHIC g900407g0404235412946.jpg GRAPHIC 3077
5 GRAPHIC g900407g0404235413317.jpg GRAPHIC 28267
6 GRAPHIC g900407g0404235413608.jpg GRAPHIC 27053
7 GRAPHIC g900407g0404235413831.jpg GRAPHIC 26289
  Complete submission text file 0001193125-25-079097.txt   1555396

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cprx-20241231.xsd EX-101.SCH 2510
19 EXTRACTED XBRL INSTANCE DOCUMENT d900407ddef14a_htm.xml XML 163768
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 25831570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)